4.5 Review

Computational challenges, tools, and resources for analyzing co- and post-transcriptional events in high throughput

Journal

WILEY INTERDISCIPLINARY REVIEWS-RNA
Volume 6, Issue 3, Pages 291-310

Publisher

WILEY
DOI: 10.1002/wrna.1274

Keywords

-

Categories

Funding

  1. NIH [R01HG006015]
  2. NYU University Research Challenge Fund

Ask authors/readers for more resources

Co- and post-transcriptional regulation of gene expression is complex and multifaceted, spanning the complete RNA lifecycle from genesis to decay. High-throughput profiling of the constituent events and processes is achieved through a range of technologies that continue to expand and evolve. Fully leveraging the resulting data is nontrivial, and requires the use of computational methods and tools carefully crafted for specific data sources and often intended to probe particular biological processes. Drawing upon databases of information pre-compiled by other researchers can further elevate analyses. Within this review, we describe the major co- and post-transcriptional events in the RNA lifecycle that are amenable to high-throughput profiling. We place specific emphasis on the analysis of the resulting data, in particular the computational tools and resources available, as well as looking toward future challenges that remain to be addressed. WIREs RNA 2015, 6:291-310. doi: 10.1002/wrna.1274 For further resources related to this article, please visit the . Conflict of interest: The authors have declared no conflicts of interest for this article.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells

Adam Kosti, Rodrigo Barreiro, Gabriela D. A. Guardia, Shiva Ostadrahimi, Erzsebet Kokovay, Alexander Pertsemlidis, Pedro A. F. Galante, Luiz O. F. Penalva

Summary: miRNAs act as key regulators of gene expression, contributing to cancer phenotypes as oncogenes or tumor suppressors. Cooperative action of miRNAs regulates biological processes and pathways, suggesting that miRNA combinations could be more effective in targeting cancer stem cells. Using combinations of tumor suppressor miRNAs may offer new routes to disrupt cancer phenotypes and growth of cancer-initiating cell populations.

CANCERS (2021)

Article Oncology

Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy

Carla Frau, Catherine Jamard, Gaspard Delpouve, Gabriela D. A. Guardia, Christelle Machon, Camilla Pilati, Clementine Le Neve, Pierre Laurent-Puig, Jerome Guitton, Pedro A. F. Galante, Luiz O. Penalva, Jean-Noel Freund, Christelle de la Fouchardiere, Michelina Plateroti

Summary: The study reveals paradoxical roles of MSI1 in both facilitating intestinal regeneration after injury and promoting drug-resistant colorectal cancer stem cells. Increased levels of MSI1 contribute to the reprogramming of progenitor cells into drug-resistant phenotypes, highlighting its importance in chemotherapy resistance and tumor grading in colorectal cancer patients. These findings shed light on the biology and plasticity of normal and cancer cell populations, presenting potential new targets for improving chemotherapy outcomes.

CANCER RESEARCH (2021)

Article Oncology

Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes

Mirella Baroni, Caihong Yi, Saket Choudhary, Xiufen Lei, Adam Kosti, Denise Grieshober, Mitzli Velasco, Mei Qiao, Suzanne S. Burns, Patricia R. Araujo, Talia DeLambre, Mi Young Son, Michelina Plateroti, Marco A. R. Ferreira, E. Paul Hasty, Luiz O. F. Penalva

Summary: RNA binding protein Msi1 plays a crucial role in glioblastoma by regulating cell cycle and DNA replication genes, impacting tumor growth and response to therapy. High levels of Msi1 are associated with poor prognosis and tumor growth in multiple cancers.

CANCERS (2021)

Article Neurosciences

Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches

Sajina Shakya, Anthony D. Gromovsky, James S. Hale, Arnon M. Knudsen, Briana Prager, Lisa C. Wallace, Luiz O. F. Penalva, H. Alex Brown, Bjarne W. Kristensen, Jeremy N. Rich, Justin D. Lathia, J. Mark Brown, Christopher G. Hubert

Summary: Glioblastoma displays significant cellular and metabolic heterogeneity, with striking differences in lipid metabolism across different microenvironments, and cancer stem cells (CSCs) also show altered lipid metabolism. The differences in lipid metabolism may not only be a product of the microenvironment, but also a reflection of cellular state, providing new insights into therapeutic targets for GBM.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Structural Characterization of the RNA-Binding Protein SERBP1 Reveals Intrinsic Disorder and Atypical RNA Binding Modes

Antoine Baudin, Alma K. Moreno-Romero, Xiaoping Xu, Emily E. Selig, Luiz O. F. Penalva, David S. Libich

Summary: RNA binding proteins (RBPs) such as SERBP1 play crucial roles in mRNA processing and translation regulation, with implications in diseases like cancer and neurodegeneration. Despite being initially identified as a hyaluronic acid binding protein, SERBP1 is now recognized for its central roles in brain function and development, including neurogenesis and synaptogenesis. Studies have shown that SERBP1 regulates One-carbon metabolism and epigenetic modification of histones, with increased expression in various cancers correlating with poor patient outcomes. Further research on SERBP1's structural and dynamic properties, as well as its interaction mechanisms with RNA, contribute to the understanding of its functions in physiological and pathological processes.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Registration-guided deep learning image segmentation for cone beam CT-based online adaptive radiotherapy

Lin Ma, Weicheng Chi, Howard E. Morgan, Mu-Han Lin, Mingli Chen, David Sher, Dominic Moon, Dat T. Vo, Vladimir Avkshtol, Weiguo Lu, Xuejun Gu

Summary: In this study, a registration-guided DL segmentation framework for online cone beam computed tomography (CBCT) image was proposed. By integrating image registration algorithms and DL segmentation models, this framework overcame the issues of low image quality and limited training data, resulting in more accurate segmentation.

MEDICAL PHYSICS (2022)

Article Oncology

Pilot Study of a Wearable Activity Monitor During Head and Neck Radiotherapy to Predict Clinical Outcomes

David J. Sher, Sepeadeh Radpour, Jennifer L. Shah, Nhat-Long Pham, Steve Jiang, Dat Vo, Baran D. Sumer, Andrew T. Day

Summary: In this pilot study, although the compliance goal was not met, the majority of patients did use the wearable biometric device. Step count reduction may predict significant decline in quality of life before it occurs, while heart rate showed no association with any endpoints.

JCO CLINICAL CANCER INFORMATICS (2022)

Article Oncology

T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer

Eric J. Hsu, Jameson T. Mendel, Kristin A. Ward, Mariam El-Ashmawy, Minjae Lee, Hak Choy, Kenneth D. Westover, Dat T. Vo, Robert D. Timmerman, David J. Sher, Puneeth Iyengar

Summary: This study analyzed the treatment outcomes of 90 patients with T1-2 non-small cell lung cancer who received five-fraction stereotactic ablative radiotherapy (SABR). The results identified the clinical parameters predictive of treatment failures with these regimens, providing guidance for treatment selection.

ADVANCES IN RADIATION ONCOLOGY (2022)

Article Oncology

Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients

Eric J. Hsu, Jamie Thomas, Elizabeth A. Maher, Michael Youssef, Robert D. Timmerman, Zabi Wardak, Minjae Lee, Tu D. Dan, Toral R. Patel, Dat T. Vo

Summary: This study found that neutrophilia before radiation, pre-radiation NLR, and post-radiation thrombocytopenia were predictors of poor survival in glioma patients.

FRONTIERS IN ONCOLOGY (2022)

Article Clinical Neurology

Socioeconomic and demographic determinants of radiation treatment and outcomes in glioblastoma patients

Eric J. J. Hsu, Jamie Thomas, Robert D. D. Timmerman, Zabi Wardak, Tu D. D. Dan, Toral R. R. Patel, Nina N. N. Sanford, Dat T. T. Vo

Summary: The study identified age and total resection surgery as predictors of overall survival in glioblastoma patients, while increased radiation fractions and history of depressive disorder were associated with decreased progression. Patients with depressive disorder history had more neuro-oncology office visits.

FRONTIERS IN NEUROLOGY (2022)

Editorial Material Oncology

Artificial Intelligence-Empowered Radiation Oncology Residency Education

Young Suk Kwon, Michael Dohopolski, Howard Morgan, Aurelie Garant, David Sher, Asal Rahimi, Nina N. Sanford, Dat T. Vo, Kevin Albuquerque, Kiran Kumar, Robert Timmerman, Steve B. Jiang

PRACTICAL RADIATION ONCOLOGY (2023)

Article Oncology

Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas

Eric J. Hsu, Jamie Thomas, Elizabeth A. Maher, Michael Youssef, Robert D. Timmerman, Zabi Wardak, Tu D. Dan, Toral R. Patel, Dat T. Vo

Summary: CDKN2A, CDKN2B, and MTAP predict poor prognosis in IDHwt glioblastomas. TERT and CDKN2A mutations are associated with worse survival only when treated with lower radiation doses.

DISCOVER ONCOLOGY (2022)

Article Oncology

Artificial intelligence guided physician directive improves head and neck planning quality and practice Uniformity: A prospective study

Maryam Mashayekhi, Rafe McBeth, Dan Nguyen, Allen Yen, Zipalkumar Trivedi, Dominic Moon, Vlad Avkshtol, Dat Vo, David Sher, Steve Jiang, Mu-Han Lin

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial

David J. Sher, Dominic H. Moon, Dat Vo, Jing Wang, Liyuan Chen, Michael Dohopolski, Randall Hughes, Baran D. Sumer, Chul Ahn, Vladimir Avkshtol

Summary: This prospective phase II study indicates that elective neck irradiation is no longer mandatory for head and neck squamous cell carcinoma treatment, and radiation therapy can effectively reduce tumor recurrence and improve patients' quality of life.

CLINICAL CANCER RESEARCH (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

3D printed integrated bolus/headrest for radiation therapy for malignancies involving the posterior scalp and neck

Eric J. Hsu, David Parsons, Tsuicheng Chiu, Andrew R. Godley, David J. Sher, Dat T. Vo

Summary: We utilized a custom 3D-printed integrated bolus and headrest to irradiate malignancies involving the posterior scalp, and found that it allowed for comfortable, consistent, and reproducible treatment setup while minimizing the risk of creating air gaps.

3D PRINTING IN MEDICINE (2022)

No Data Available